THE Summit for ChangeMakers Using AI in Biopharma

25/10/2018 - 26/10/2018

THE Summit for ChangeMakers Using AI in Biopharma

The AI Applications in Biopharma Summit 2018 is the only event to convene key strategic biopharma stakeholders and data driven disruptors to discuss their experiences, obstacles, opportunities for partnerships, and strategies to implement AI technologies in the research and drug development process.

Interest in AI driven technologies is growing fast among leaders in the biopharma industry. The AI Applications Summit provides the opportunity to discuss the practical steps for implementing these technologies to achieve the greatest impact and ROI. The event will enable industry leaders to find partners to help keep the AI in Biopharma movement growing and moving forward.



Why Attend?

Start Making Progress

How do you choose the projects that will produce the best results? Hear from industry colleagues Sanofi, Genentech, Eli Lilly and Bristol-Myers Squibb who are pioneers in the movement.

Make Valuable Connections

Engage in meaningful 1-to-1 discussions with research and data driven disruptors, innovative biopharma and technology companies to form essential connections/partnerships.

Find Out What Questions To Ask

You know you want AI technology in your business, but where do you start? Gain a better understanding of the questions you need to ask to formulate your optimal business model.

Meet The ChangeMakers

With the CEOs of BERG, Insilico Medicine, twoXAR, Numerate and more sharing their experiences, the AI Applications Summit is the ultimate meeting of biopharma and technology.

Summit at a Glance

  • AI in Research and Development: Hear how AI can be used to identify molecules that are ideal candidates for clinical development and testing and how near term ROI can be achieved using AI and machine learning.
  • AI in Clinical Trials: Discover how AI can be used to influence the design and optimization of clinical trials and the recruitment and retention of patients and how getting the corporate culture right will improve business outcome conversations and results.
  • Moving from the ‘Science of AI’ to ‘Using AI Tools in Pharma Science’: Understand from Chief Data Officers why data is the new key asset and explore real world evidence and AI and how we can take the next steps forward to start directly impacting care.